Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02273115 · ClinicalTrials.gov registry record · Phase 4
Foley With Oxytocin Versus Foley no Oxytocin for Induction of Labor
A Phase 4 study of Labor; Forced or Induced, Affecting Fetus or Newborn, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- Phase 4
- Development phase
- 323
- Enrollment target
- 2
- Study locations
NCT02273115 is a Phase 4 study of Labor; Forced or Induced, Affecting Fetus or Newborn that has completed, run by Christiana Care Health Services. The registered enrollment target is 323 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT02273115, a Phase 4 study of Labor; Forced or Induced, Affecting Fetus or Newborn, has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 323 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overall purpose of this study is to determine if adding oxytocin to a Foley catheter for induction of labor will increase the rate of delivery within 24 hours stratified by parity.
Conditions Studied
Interventions
- DRUG Oxytocin
- DEVICE Transcervical Foley catheter
Study Locations (2)
Delaware
- Christiana Care Health Services - Newark
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-09-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02273115
The ClinicalTrials.gov registry entry for NCT02273115 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 323 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christiana Care Health Services, which has 82 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Labor; Forced or Induced, Affecting Fetus or Newborn appearing as the primary indexed condition, and to 2 interventions - of which Oxytocin is the first listed.
NCT02273115 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Delaware, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02273115 about?
NCT02273115 is a clinical study titled "Foley With Oxytocin Versus Foley no Oxytocin for Induction of Labor". The overall purpose of this study is to determine if adding oxytocin to a Foley catheter for induction of labor will increase the rate of delivery within 24 hours stratified by parity.
What is the current status of trial NCT02273115?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 323 participants. The study started on 2014-10. Estimated completion is 2016-09-11.
What conditions does trial NCT02273115 study?
This clinical trial studies the following conditions: Labor; Forced or Induced, Affecting Fetus or Newborn.
What interventions are being tested in trial NCT02273115?
The interventions under investigation include: Oxytocin (DRUG), Transcervical Foley catheter (DEVICE).
Who is sponsoring clinical trial NCT02273115?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02273115 being conducted?
This trial has 2 study locations across Delaware, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Labor; Forced or Induced, Affecting Fetus or Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.